Cipaglucosidase alfa

西哌糖苷酶 α

Report date: 2025/07/04 11:04:07

Base Information

Drug NameCipaglucosidase alfa
Drug Alias NameRecombinant-human-acid-alpha-glucosidase-enzymecipaglucosidase alfa-atgaPombilitiATB-200AT-GAA +[6] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionAlpha glucosidase replacements
TargetsGlycogen
Therapy Area/IndicationsGlycogen Storage Disease Type II
Global Approved IndicationsGlycogen Storage Disease Type II
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2023/03/20
Country/TerritoryBelgiumBosnia and HerzegovinaBulgaria +[25] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAmicus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmicus Therapeutics Us IncAmicus Therapeutics Europe LtdAmicus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG